1018 related articles for article (PubMed ID: 1688702)
1. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
[TBL] [Abstract][Full Text] [Related]
2. "Activated" keratinocyte phenotype is unifying feature in conditions which predispose to squamous cell carcinoma of the skin.
Smoller BR; Krueger J; McNutt NS; Hsu A
Mod Pathol; 1990 Mar; 3(2):171-5. PubMed ID: 1691494
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenesis in porokeratosis. Evidence for a role relating to chronic growth activation of keratinocytes.
Gray MH; Smoller BS; McNutt NS
Am J Dermatopathol; 1991 Oct; 13(5):438-44. PubMed ID: 1719839
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural findings in epidermolysis bullosa.
Smith LT
Arch Dermatol; 1993 Dec; 129(12):1578-84. PubMed ID: 7504435
[TBL] [Abstract][Full Text] [Related]
5. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
[TBL] [Abstract][Full Text] [Related]
6. A specific defect in glycosylation of epidermal cell membranes. Definition in skin from patients with epidermolysis bullosa simplex.
Fine JD; Griffith RD
Arch Dermatol; 1985 Oct; 121(10):1292-6. PubMed ID: 2412497
[TBL] [Abstract][Full Text] [Related]
7. Keratin expression in epidermolysis bullosa simplex (Dowling-Meara).
Tidman MJ; Eady RA; Leigh IM; MacDonald DM
Acta Derm Venereol; 1988; 68(1):15-20. PubMed ID: 2449006
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.
Dammak A; Zribi J; Boudaya S; Mseddi M; Meziou TJ; Masmoudi A; Ellouze Z; Keskes H; Turki H
Int J Dermatol; 2009 Jun; 48(6):588-91. PubMed ID: 19538366
[TBL] [Abstract][Full Text] [Related]
9. HLA and epidermolysis bullosa. Association between the HLA complex and recessive dystrophic epidermolysis bullosa.
Vaidya S; Tyring SK; Johnson LB; Fine JD
Arch Dermatol; 1991 Oct; 127(10):1524-7. PubMed ID: 1929459
[TBL] [Abstract][Full Text] [Related]
10. Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry.
Fine JD; Johnson LB; Weiner M; Stein A; Cash S; DeLeoz J; Devries DT; Suchindran C;
Am J Kidney Dis; 2004 Oct; 44(4):651-60. PubMed ID: 15384016
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
[TBL] [Abstract][Full Text] [Related]
12. Transient intraepidermal bullous reaction after skin graft for toxic epidermal necrolysis. Ultrastructural and immunohistochemical features similar to those of inherited epidermolysis bullosa simplex.
Bourgault I; Prost C; André C; Villada G; Wechsler J; Chosidow O; Revuz J
Arch Dermatol; 1991 Sep; 127(9):1369-74. PubMed ID: 1892406
[TBL] [Abstract][Full Text] [Related]
13. Activated keratinocytes in the epidermis of hypertrophic scars.
Machesney M; Tidman N; Waseem A; Kirby L; Leigh I
Am J Pathol; 1998 May; 152(5):1133-41. PubMed ID: 9588880
[TBL] [Abstract][Full Text] [Related]
14. Recessive epidermolysis bullosa simplex phenotype reproduced in vitro: ablation of keratin 14 is partially compensated by keratin 17.
El Ghalbzouri A; Jonkman M; Kempenaar J; Ponec M
Am J Pathol; 2003 Nov; 163(5):1771-9. PubMed ID: 14578178
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of L-arginine metabolism pathway genes in chronic wounds in recessive dystrophic epidermolysis bullosa.
Wessagowit V; Mallipeddi R; McGrath JA; South AP
Clin Exp Dermatol; 2004 Nov; 29(6):664-8. PubMed ID: 15550148
[TBL] [Abstract][Full Text] [Related]
16. Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Rodeck U; Fertala A; Uitto J
Exp Dermatol; 2007 Jun; 16(6):465-7. PubMed ID: 17518985
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of the collagenase promoter in recessive dystrophic epidermolysis bullosa fibroblasts: role of endogenously activated AP-1.
Unemori EN; Mauch C; Hoeffler W; Kim Y; Amento EP; Bauer EA
Exp Cell Res; 1994 Apr; 211(2):212-8. PubMed ID: 8143767
[TBL] [Abstract][Full Text] [Related]
18. From newborn to adult: phenotypic and functional properties of skin equivalent and human skin as a function of donor age.
Michel M; L'Heureux N; Auger FA; Germain L
J Cell Physiol; 1997 May; 171(2):179-89. PubMed ID: 9130465
[TBL] [Abstract][Full Text] [Related]
19. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
